Investors
Portfolio Metrics
35+
Approved products
12
Development-stage therapies
14
Blockbuster $1Bn+ therapies in portfolio
~13 Years
Portfolio weighted average royalty duration
Financial Metrics
$2.1Bn
Adjusted Cash Receipts (2021)
$1.8Bn
Adjusted Cash Flow (2021)
$1.8Bn
Average annual capital deployment since 2012